US FDA panel rejects broad use of Pfizer coronavirus boosters in blow to Biden plan

A panel of expert outside advisers to the US Food and Drug Administration voted against broadly approving Covid-19 vaccine booster shots on Friday, instead recommending emergency use authorisation for the narrower group of older or high-risk patients.The panel voted overwhelmingly against approving boosters for Americans age 16 and older, potentially undermining the Biden administration’s plan to roll out third shots of the Pfizer/BioNTech vaccine as soon as next week.Panel members, however,…

Share this:

What do you think?

Written by Headlines

Mainstream media is often "Fake News." Nevertheless, one needs to see what others are seeing and then read with discernment.

Leave a Reply

Your email address will not be published. Required fields are marked *

France recalls ambassadors from US and Australia in protest over submarine deal

China’s bid to join Pacific Rim trade pact heaps pressure on US to step up regional economic strategy